CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Catalent Inc Company Snapshot
Catalent Inc operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Catalent Inc with three other companies in this sector in UNITED STATES : Elanco Animal Health Inc (2019 sales of $3.07 billion of which 100% was Manufactures & markets products for comp), Endo International PLC ($2.91 billion of which 36% was Sterile Injectables), and H. Lundbeck A/S ($2.55 billion of which 100% was Pharmaceuticals).

Sales Analysis. Catalent Inc reported sales of $2.52 billion for the fiscal year ending June of 2019. This represents an increase of 2.2% versus 2018, when the company's sales were $2.46 billion. Sales at Catalent Inc have increased during each of the previous five years (and since 2014, sales have increased a total of 38%). Sales of Biologics and Specialty Drug Delivery saw an increase that was more than double the company's growth rate: sales were up 23.3% in 2019, from $601.90 million to $742.10 million. Catalent Inc also saw significant increases in sales in Oral Drug Delivery (up 8.0% to $619.90 million) . Not all segments of Catalent Inc experienced an increase in sales in 2019: sales of Clinical Supply Services fell 25.3% to $321.40 million. Catalent Inc also experienced decreases in sales in Softgel Technologies (down 4.9% to $872.10 million) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Catalent Inc
  Stock Performance Chart for Catalent Inc
 
  Stock Data: Recent Stock Performance:
  Current Price (7/31/2020): 87.34
(Figures in U.S. Dollars)
1 Week 7.0%   13 Weeks 20.1%  
4 Weeks 31.1%   52 Weeks 58.5%  
 
Catalent Inc Key Data:
  Ticker: CTLT Country: United States
  Exchanges: NYSE Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 2,518,000,000
(Year Ending Jan 2020).
Employees: 12,300
  Currency: U.S. Dollars Market Cap: 13,528,966,000
  Fiscal Yr Ends: June Shares Outstanding: 154,900,000
  Share Type: Ordinary Closely Held Shares: 1,036,427
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.